Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01473485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors

StatusActive, Not Recruiting
PhaseNot applicable
SponsorInSightec
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary and study completion dates: Dec 2022 to Dec 2026v11
  2. Minor Re-verified, no change to tracked fieldsv10
  3. Minor Trial status: Recruiting to Active, Not Recruiting Site details revisedv9 Show 1 more changeShow less
    • Site details revised
  4. Minor Re-verified, no change to tracked fieldsv8
  5. Notable Primary and study completion dates: Dec 2018 to Dec 2022v7
Show 5 earlier versionsHide 5 earlier versions
  1. Notable Primary and study completion dates: Dec 2017 to Dec 2018v6
  2. Notable Primary and study completion dates: Dec 2015 to Dec 2017v5
  3. Notable Primary and study completion dates: Dec 2014 to Dec 2015 Site contact updatedv4 Show 1 more changeShow less
    • Site contact updated
  4. Notable Primary and study completion dates: Apr 2012 to Dec 2014 Study arms: 0 to 1v3 Show 1 more changeShow less
    • Study arms: 0 to 1
  5. Minor Site contact updatedv2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
42 trials monitored
See 1 trial at risk
668 trials monitored
See 40 trials at risk
A Study to Evaluate the Safety and Feasibility of Transcranial MRI-Guided Focused Ultrasound Surgery in the Treatment of Brain Tumors
Trial Details
NCT Number NCT01473485
Lead Sponsor InSightec
Conditions Glioma, Metastatic Brain Cancer
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov